ARTICLE | Company News
Amdipharm plc, Recordati sales and marketing update
July 20, 2009 7:00 AM UTC
Amdipharm granted Recordati exclusive rights to market TransAct local action transcutaneous (LAT) in Italy and Portugal for symptomatic relief of localized pain involving the musculoskeletal system. T...